S
Stephen D. Walter
Researcher at McMaster University
Publications - 522
Citations - 62049
Stephen D. Walter is an academic researcher from McMaster University. The author has contributed to research in topics: Randomized controlled trial & Population. The author has an hindex of 112, co-authored 513 publications receiving 57012 citations. Previous affiliations of Stephen D. Walter include Christian Medical College & Hospital & McMaster-Carr.
Papers
More filters
Journal ArticleDOI
Development and reliability of a system to classify gross motor function in children with cerebral palsy
Robert J. Palisano,Peter Rosenbaum,Stephen D. Walter,Dianne J Russell,Ellen Wood,Barbara Galuppi +5 more
TL;DR: A five‐level classification system analogous to the staging and grading systems used in medicine, which has application for clinical practice, research, teaching, and administration is developed.
Journal ArticleDOI
Measuring change over time: assessing the usefulness of evaluative instruments.
TL;DR: Responsiveness should join reliability and validity as necessary requirements for instruments designed primarily to measure change over time in psychometric measures.
Journal ArticleDOI
Sample size and optimal designs for reliability studies
TL;DR: A functional approximation to earlier exact results is shown to have excellent agreement with the exact results and one can use it easily without intensive numerical computation.
Journal ArticleDOI
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials
TL;DR: An alternative model is presented that evaluates the differences between treatment and placebo in two sets of clinical trials, and preserves the randomization of the originally assigned patient groups.
Journal ArticleDOI
Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer
Sylvie Giacchetti,B. Perpoint,Rachid Zidani,N. Le Bail,R. Faggiuolo,Christian Focan,Philippe Chollet,J.F. Llory,Y. Letourneau,Bruno Coudert,F. Bertheaut-Cvitkovic,D. Larregain-Fournier,A. Le Rol,Stephen D. Walter,Rosalyn M. Adam,J.L. Misset,Francis Lévi +16 more
TL;DR: By chronomodulating 5-FU-LV, the authors were able to add l-OHP without compromising dose-intensities and significantly improved the antitumor efficacy of this regimen.